e-Drug3D

1344

FLUPHENAZINE DECANOATE


INN
FLUPHENAZINE DECANOATE

(has an active metabolite)

cas 5002-47-1
CLASS

NERVOUS SYSTEM
ANTIPSYCHOTIC
PHENOTHIAZINE DERIVATIVE
ANTAGONIST
HYDROLYSED BY ESTERASES

ROUTE (list)

INJECTION

ATC code

N05AB02

PK parameters

Target

TARGET D2 DOPAMINE RECEPTOR

DrugCentral

D(2) dopamine receptor UNIPROT P14416 DRD2

D(2) dopamine receptor UNIPROT P14416 DRD2

Download SDF file Decanoic acid, 2-[4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester

Formula:
C32H44F3N3O2S

Calculated chemical properties:

MW 591.77
NB_atoms 41
XLogP 8.00
PSA 39.664
NB_HD 0
NB_HA 5
fsp3 0.59
Lipinski(0=no;1=yes) 0

FDA
NDA 070762 (pdf not found) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 016727 (pdf not found) INN (FLUPHENAZINE DECANOATE) PROLIXIN DECANOATE (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 1972 DISCONTINUED
NDA 071413 (label) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE DECANOATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 1987
NDA 074531 (pdf not found) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE DECANOATE (HIKMA) APPROVAL= AP YEAR= 1996
NDA 074795 (pdf not found) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE DECANOATE (TEVA PARENTERAL) APPROVAL= AP YEAR= 1996 DISCONTINUED
NDA 074966 (pdf not found) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE DECANOATE (HOSPIRA) APPROVAL= AP YEAR= 1998 DISCONTINUED
NDA 075918 (pdf not found) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE DECANOATE (MYLAN LABS LTD) APPROVAL= AP YEAR= 2001
NDA 203732 (pdf not found) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE DECANOATE (PH HEALTH) APPROVAL= AP YEAR= 2014
NDA 207739 (pdf not found) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE DECANOATE (EUGIA PHARMA) APPROVAL= AP YEAR= 2017
NDA 215509 (pdf not found) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE DECANOATE (GLAND) APPROVAL= AP YEAR= 2023
NDA 215365 (pdf not found) INN (FLUPHENAZINE DECANOATE) FLUPHENAZINE DECANOATE (MSN) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL